USA |PINK |USD
Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, and the Asia Pacific. The company is involved in hemp growing operations, outsourced CBD extraction, and cannabidiol (CBD) product sales activities, as well as the development and commercialization of its therapeutic products. Its products include anibidiol, a natural complementary feed product for companion animals; and cannaQIX, a nutraceutical product containing organic hemp extract with CBD vitamins and zinc to reduce stress and support mental and nervous functions in humans, as well as topical and skin care products. The company also offers various nutraceutical products, such as cannaQIX®nite to aid sleep; cannaPEAL to introduce various markets to the benefits of hemp seed oil-based products; and cannaDOL to provide relief to athletes in the form of a topical application. In addition, it imports and sells its medicinal cannabis product, cannaQIX50 to patients in Brazil. Creso Pharma Limited has a strategic collaboration agreement with Hempmate AG Switzerland and Burleigh Heads Cannabis Pty Ltd. The company was incorporated in 2015 and is headquartered in Sydney, Australia.
|Public Float||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||24.91%||Ex-Dividend Date|
|Held by Institutions||2.86%||IPO Date||-|
|Dec 21||Dec 20||Dec 19|
|Dec 21||Sep 21||Jun 21|
Creso pharma trades on the OTC Markets stock market in USA under the ticker symbol "COPHF". Creso pharma’s stock symbol can also be displayed as "OTCMKTS:COPHF".
Creso pharma (OTCMKTS:COPHF) is owned by 2.85% institutional shareholders and by 24.91% insiders. The rest is owned by the public.
Explore More Details on Creso pharma's “Ownership” Section
Creso pharma's key executive team includes the following managers:
Creso pharma (OTCMKTS:COPHF) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.
Currently the number of employees working for Creso pharma is 0.
Creso pharma (OTCMKTS:COPHF) is headquartered in WA, Australia.
Creso pharma’s mailing address is 145 Stirling Highway, Nedlands, WA, Australia, 6009.
The company’s phone number is 61 8 9389 3180.